MIRIAM R BROWN M.D.
Prescription History 1225035306
Ophthalmology in Moorestown, NJ
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MIRIAM R BROWN M.D., an active Ophthalmology specialist practicing in Moorestown, NJ. Our medical registry currently tracks 27 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 3,649 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 1,014 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NJ PrescribersVs. NJ Avg |
|---|---|---|---|
| Latanoprost | 1,014 | $14.03 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2024, this provider wrote 1,014 Medicare prescriptions for Latanoprost, about 8 times the volume of the typical New Jersey prescriber of this medication (126.6). Medicare paid an average of $14.03 per fill, versus $12.45 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 2,354.5 30-Day Fills standardized to 30-day supplies 69,392 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate | 386 | $205.27 | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 386 Medicare prescriptions for Brimonidine Tartrate, about 6.7 times the volume of the typical New Jersey prescriber of this medication (57.9). Medicare paid an average of $205.27 per fill, versus $63.07 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 820.1 30-Day Fills standardized to 30-day supplies 24,200 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 358 | $22.10 | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 358 Medicare prescriptions for Dorzolamide-Timolol, about 4.3 times the volume of the typical New Jersey prescriber of this medication (82.9). Medicare paid an average of $22.10 per fill, versus $18.49 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 736.6 30-Day Fills standardized to 30-day supplies 22,008 Days of Medication total across all patients in 2024 | |||
| LumiganBimatoprost | 296 | $570.58 | ▲ More than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 296 Medicare prescriptions for Lumigan, about 4.7 times the volume of the typical New Jersey prescriber of this medication (62.7). Medicare paid an average of $570.58 per fill, versus $498.05 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 686.3 30-Day Fills standardized to 30-day supplies 20,311 Days of Medication total across all patients in 2024 | |||
| Cyclosporine | 208 | $691.03 | ▲ More than typical |
About Cyclosporine: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 208 Medicare prescriptions for Cyclosporine, about 5.7 times the volume of the typical New Jersey prescriber of this medication (36.7). Medicare paid an average of $691.03 per fill, versus $537.74 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 461 30-Day Fills standardized to 30-day supplies 14,025 Days of Medication total across all patients in 2024 | |||
| Timolol Maleate | 197 | $30.81 | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2024, this provider wrote 197 Medicare prescriptions for Timolol Maleate, about 3 times the volume of the typical New Jersey prescriber of this medication (65.9). Medicare paid an average of $30.81 per fill, versus $25.68 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 458.3 30-Day Fills standardized to 30-day supplies 13,607 Days of Medication total across all patients in 2024 | |||
| RestasisCyclosporine | 184 | $1,137.18 | ▲ More than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 184 Medicare prescriptions for Restasis, about 3.4 times the volume of the typical New Jersey prescriber of this medication (54.9). Medicare paid an average of $1,137.18 per fill, versus $1,032.69 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 352 30-Day Fills standardized to 30-day supplies 10,455 Days of Medication total across all patients in 2024 | |||
| Prednisolone Acetate | 177 | $29.20▼ below NJ avg | ▲ More than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. In 2024, this provider wrote 177 Medicare prescriptions for Prednisolone Acetate, about 1.5 times the volume of the typical New Jersey prescriber of this medication (120.6). Medicare paid an average of $29.20 per fill, versus $39.79 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 225.4 30-Day Fills standardized to 30-day supplies 5,405 Days of Medication total across all patients in 2024 | |||
| Dorzolamide Hcl | 138 | $29.51 | ▲ More than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. Topically effective ocular hypotensive carbonic anhydrase inhibitor. In 2024, this provider wrote 138 Medicare prescriptions for Dorzolamide Hcl, about 3.1 times the volume of the typical New Jersey prescriber of this medication (44.5). Medicare paid an average of $29.51 per fill, versus $21.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 284.6 30-Day Fills standardized to 30-day supplies 8,488 Days of Medication total across all patients in 2024 | |||
| ErythromycinErythromycin Base | 83 | $10.58▼ below NJ avg | ▲ More than typical |
About Erythromycin: This medication is used to treat certain eye infections (such as conjunctivitis). Show more ▾ It is also used to prevent certain eye infections in newborns. It belongs to a class of drugs known as macrolide antibiotics. Erythromycin works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. In 2024, this provider wrote 83 Medicare prescriptions for Erythromycin, about 2.1 times the volume of the typical New Jersey prescriber of this medication (39.8). Medicare paid an average of $10.58 per fill, versus $13.02 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 83 30-Day Fills standardized to 30-day supplies 897 Days of Medication total across all patients in 2024 | |||
| XiidraLifitegrast | 80 | $1,135.61▼ below NJ avg | ▲ More than typical |
About Xiidra: This medication is used to treat dry eye disease. Show more ▾ An LFA-1 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1) antagonist that is used in the treatment of DRY EYE SYNDROMES. In 2024, this provider wrote 80 Medicare prescriptions for Xiidra, about 2 times the volume of the typical New Jersey prescriber of this medication (40.8). Medicare paid an average of $1,135.61 per fill, versus $1,148.13 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 138 30-Day Fills standardized to 30-day supplies 4,140 Days of Medication total across all patients in 2024 | |||
| Alphagan PBrimonidine Tartrate | 69 | $390.53 | ▲ More than typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 69 Medicare prescriptions for Alphagan P, about 2 times the volume of the typical New Jersey prescriber of this medication (35.1). Medicare paid an average of $390.53 per fill, versus $379.90 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 114.9 30-Day Fills standardized to 30-day supplies 3,343 Days of Medication total across all patients in 2024 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 62 | $12.13 | ▲ More than typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2024, this provider wrote 62 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about 1.3 times the volume of the typical New Jersey prescriber of this medication (45.9). Medicare paid an average of $12.13 per fill, versus $11.05 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 62.3 30-Day Fills standardized to 30-day supplies 957 Days of Medication total across all patients in 2024 | |||
| Travoprost | 59 | $177.04 | ▲ More than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 59 Medicare prescriptions for Travoprost, about 1.8 times the volume of the typical New Jersey prescriber of this medication (33.2). Medicare paid an average of $177.04 per fill, versus $167.60 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 111.7 30-Day Fills standardized to 30-day supplies 3,242 Days of Medication total across all patients in 2024 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 46 | $449.37 | ▲ More than typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2024, this provider wrote 46 Medicare prescriptions for Simbrinza, about 1.4 times the volume of the typical New Jersey prescriber of this medication (32.9). Medicare paid an average of $449.37 per fill, versus $279.38 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 88.8 30-Day Fills standardized to 30-day supplies 2,643 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 46 | $226.40 | ▲ More than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. In 2024, this provider wrote 46 Medicare prescriptions for Brimonidine Tartrate-Timolol, about 1.3 times the volume of the typical New Jersey prescriber of this medication (34.6). Medicare paid an average of $226.40 per fill, versus $178.06 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 72 30-Day Fills standardized to 30-day supplies 1,964 Days of Medication total across all patients in 2024 | |||
| Bimatoprost | 43 | $109.55▼ below NJ avg | ▲ More than typical |
About Bimatoprost: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 43 Medicare prescriptions for Bimatoprost, about 1.9 times the volume of the typical New Jersey prescriber of this medication (23). Medicare paid an average of $109.55 per fill, versus $116.53 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 87.6 30-Day Fills standardized to 30-day supplies 2,563 Days of Medication total across all patients in 2024 | |||
| Doxycycline Hyclate | 34 | $31.81 | ≈ Typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 34 Medicare prescriptions for Doxycycline Hyclate, about the same volume as the typical New Jersey prescriber of this medication (30.6). Medicare paid an average of $31.81 per fill, versus $12.55 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 40 30-Day Fills standardized to 30-day supplies 692 Days of Medication total across all patients in 2024 | |||
| Brinzolamide | 34 | $175.07▼ below NJ avg | ≈ Typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. An antiglaucoma agent. In 2024, this provider wrote 34 Medicare prescriptions for Brinzolamide, about the same volume as the typical New Jersey prescriber of this medication (29.9). Medicare paid an average of $175.07 per fill, versus $196.69 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 68.4 30-Day Fills standardized to 30-day supplies 2,024 Days of Medication total across all patients in 2024 | |||
| Ketorolac Tromethamine | 23 | $14.93▼ below NJ avg | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2024, this provider wrote 23 Medicare prescriptions for Ketorolac Tromethamine, about a quarter of the volume of the typical New Jersey prescriber of this medication (84.7). Medicare paid an average of $14.93 per fill, versus $21.80 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 25.7 30-Day Fills standardized to 30-day supplies 544 Days of Medication total across all patients in 2024 | |||
| MieboPerfluorohexyloctane/Pf | 20 | $1,105.93 | ▼ Less than typical |
About Miebo: This medication is used to relieve dry, irritated eyes. Show more ▾ Perfluorohexyloctane works by keeping your tears from drying up. This keeps the eye moist, helps protect the eye from injury and infection, and decreases symptoms of dry eyes such as burning, itching, and feeling as if something is in the eye. Used for removing silicone oil from the surface of silicone intraocular lenses; MF is C14F13H17. In 2024, this provider wrote 20 Medicare prescriptions for Miebo, about half the volume of the typical New Jersey prescriber of this medication (33.8). Medicare paid an average of $1,105.93 per fill, versus $949.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31 30-Day Fills standardized to 30-day supplies 890 Days of Medication total across all patients in 2024 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 20 | $334.62▼ below NJ avg | ▼ Less than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2024, this provider wrote 20 Medicare prescriptions for Rocklatan, about half the volume of the typical New Jersey prescriber of this medication (36.3). Medicare paid an average of $334.62 per fill, versus $510.68 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 22.7 30-Day Fills standardized to 30-day supplies 590 Days of Medication total across all patients in 2024 | |||
| TyrvayaVarenicline Tartrate | 18 | $1,125.29 | ▼ Less than typical |
About Tyrvaya: Varenicline is used to treat dry eyes. Show more ▾ It works by increasing the amount of tears you make. A benzazepine derivative that functions as an ALPHA4-BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION. In 2024, this provider wrote 18 Medicare prescriptions for Tyrvaya, about 70% of the volume of the typical New Jersey prescriber of this medication (25.6). Medicare paid an average of $1,125.29 per fill, versus $889.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2024 | |||
| CombiganBrimonidine Tartrate/Timolol | 17 | $358.69▼ below NJ avg | ▼ Less than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2024, this provider wrote 17 Medicare prescriptions for Combigan, about half the volume of the typical New Jersey prescriber of this medication (35.1). Medicare paid an average of $358.69 per fill, versus $368.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 19.7 30-Day Fills standardized to 30-day supplies 575 Days of Medication total across all patients in 2024 | |||
| CequaCyclosporine | 15 | $1,317.98 | ▼ Less than typical |
About Cequa: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 15 Medicare prescriptions for Cequa, about a third of the volume of the typical New Jersey prescriber of this medication (44.5). Medicare paid an average of $1,317.98 per fill, versus $972.09 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2024 | |||
| RhopressaNetarsudil Mesylate | 11 | $784.52 | ▼ Less than typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. A Rho kinase inhibitor with norepinephrine transport inhibitory activity that reduces production of aqueous humor. In 2024, this provider wrote 11 Medicare prescriptions for Rhopressa, about a quarter of the volume of the typical New Jersey prescriber of this medication (44.6). Medicare paid an average of $784.52 per fill, versus $469.33 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29 30-Day Fills standardized to 30-day supplies 860 Days of Medication total across all patients in 2024 | |||
| XdemvyLotilaner | 11 | $1,820.70▼ below NJ avg | ▼ Less than typical |
About Xdemvy: This medication is used to treat a parasitic infection of the eye (Demodex blepharitis) that can especially affect the eyelids. Show more ▾ It belongs to a class of drugs known as antiparasitics. Lotilaner works by killing parasites. This medication treats only parasitic eye infections. It will not work for other types of eye infections. In 2024, this provider wrote 11 Medicare prescriptions for Xdemvy, about a third of the volume of the typical New Jersey prescriber of this medication (26.4). Medicare paid an average of $1,820.70 per fill, versus $1,854.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 17.3 30-Day Fills standardized to 30-day supplies 518 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MIRIAM R BROWN M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Moorestown, NJ practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NJ prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
